Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (symbol: HUM) is a leading private health insurer in the United States, with a primary focus on Medicare Advantage plans. The company has carved out a significant niche in the healthcare market by specializing in government-sponsored programs. Nearly all of Humana's medical memberships come from individual and group Medicare Advantage plans, Medicaid, and the military's Tricare program. This makes it a pivotal player in providing health insurance solutions to a diverse segment of the population.
In addition to its core insurance offerings, Humana is a frontrunner in stand-alone prescription drug plans, particularly for seniors enrolled in traditional fee-for-service Medicare. This is part of their broader commitment to ensuring comprehensive healthcare accessibility for all members.
Humana continuously strives to innovate and improve its services, recognizing that healthcare needs are dynamic and vary among individuals, families, and communities. The company's cultural foundation is deeply rooted in helping members achieve optimal health by delivering personalized and simplified healthcare experiences. Their array of services includes not only medical insurance but also primary-care services, at-home healthcare services, and pharmacy benefit management.
The company's recent achievements and current projects reflect its commitment to holistic health solutions. Through CenterWell, Humana provides the latest updates and resources aimed at helping people live their healthiest lives on their terms, whenever and wherever they need it.
Humana's employees are central to its mission. The company has built an organization of dynamic talent, whose experience and passion are focused on putting the customer first. This dedication is evident in their innovative approach to healthcare, which continuously adapts to meet evolving needs.
With its strong financial condition and strategic partnerships, Humana is well-positioned to continue its leadership in the healthcare industry. Whether you are an investor looking for reliable stock performance or a member seeking high-quality healthcare services, Humana remains a standout choice.
Humana Inc. (NYSE: HUM) is expanding its agreement with Allina Health to enhance value-based care for Medicare Advantage members in Minnesota, effective January 1, 2022. This multi-year initiative aims to personalize patient care through proactive health screenings and improved management of chronic conditions. The agreement aligns with Humana's commitment to quality care, linking physician reimbursement to patient health outcomes rather than service volume. Additionally, Humana ranks first in customer experience among health insurers according to the 2021 Forrester CX Index.
Humana Inc. (NYSE: HUM) announced the addition of Albertsons Companies pharmacies to its preferred Medicare Part D pharmacy network, effective January 1, 2022. This expansion enhances affordability and access for Humana's Prescription Drug Plan (PDP) members, who will benefit from over 11,000 preferred pharmacy locations nationwide, including familiar chains like Costco, Walmart, and Kroger. TJ Gibb, VP of Medicare Prescription Drug Plans, emphasized the commitment to improving member experience and health outcomes through this strategic expansion.
Humana Inc. (NYSE: HUM) released its eighth annual Value-based Care (VBC) Report, revealing significant benefits for Medicare Advantage members under VBC agreements. Members saved 245,000 hospital days, with a 7% reduction in hospital admissions and a 12% drop in ER visits. The report highlights a 13.4% reduction in total medical costs, equating to $3.1 billion savings, and increased telemedicine use, especially during COVID-19. The findings underscore VBC's effectiveness in improving patient outcomes and adapting care delivery amidst pandemic challenges.
Humana Inc. (NYSE: HUM) and Mays Business School at Texas A&M University announced the winners of the 2021 Humana-Mays Healthcare Analytics Case Competition. The competition engaged over 750 master's students from 75 universities, awarding a total of $80,000 in prizes. The first-place team from Georgia Tech received $50,000 for their innovative analysis addressing vaccine hesitancy among vulnerable populations. Humana aims to leverage the insights from this competition to enhance healthcare delivery and address health equity challenges.
Humana Inc. (NYSE: HUM) has added the veteran population to its Bold Goal communities, aimed at enhancing health through social determinants. This integration leverages partnerships with Veteran Service Organizations like VFW and DAV, focusing on food insecurity, social isolation, and health equity. Humana introduced the Humana Honor Medicare Advantage plan tailored for veterans, enhancing their healthcare options. The company continues to invest in hiring veterans to improve service delivery and health outcomes, reinforcing its commitment to the veteran community.
CarePlus Health Plans, a subsidiary of Humana (HUM), has achieved a 5-star rating from the Centers for Medicare & Medicaid Services (CMS) for its Medicare Advantage HMO plan in Florida. This marks the fifth time the company has received this rating, underscoring its commitment to quality healthcare and customer service. CarePlus has doubled its membership over the last six years, now serving approximately 200,000 members. The company emphasizes collaboration with healthcare providers to enhance member experiences and health outcomes.
Humana Inc. (HUM) reported 3Q21 earnings of $11.84 per diluted share (GAAP) and $4.83 (Adjusted), with year-to-date EPS at $22.77 (GAAP) and $19.40 (Adjusted). The company revised its FY 2021 EPS guidance down to $23.67 (GAAP) and $20.50 (Adjusted), citing COVID-19 impacts. Despite this, individual Medicare Advantage membership is expected to grow by 11% year-over-year, with 97% of members in 4-Star plans or above. Revenues for 3Q21 reached $20.7 billion compared to $20.1 billion in 3Q20, driven by strong core operations.
Humana Inc. has launched the new CareBreeze (HMO C-SNP) plan for Medicare beneficiaries facing chronic lung disorders, supplementing its existing CareComplete (HMO C-SNP) plan aimed at those with diabetes and heart disease. The CareBreeze plan is available during the Medicare enrollment period from Oct. 15 to Dec. 7, 2021 with coverage starting on Jan. 1, 2022. With 14% of Floridians impacted by chronic lung conditions, this initiative aims to enhance treatment quality and affordability, supported by a 5-star CMS rating for the upcoming plan year.
FAQ
What is the current stock price of Humana (HUM)?
What is the market cap of Humana (HUM)?
What is Humana Inc.'s primary focus?
What types of healthcare services does Humana provide?
Who are Humana's primary members?
How does Humana innovate in healthcare delivery?
What is CenterWell?
Why is Humana a significant player in healthcare?
How does Humana support its mission through its employees?
What sets Humana apart from other health insurers?
What recent achievements has Humana made?
How does Humana's cultural foundation influence its operations?
